Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADSC for Knee Osteoarthritis
NCT02357485Phase 1Completed
- Start
- Mar 2014
- Primary completion
- May 2015
- Modality
- Stem Cell Therapies
01
Overview
Phase 1, open-label trial of adipose derived mesenchymal stromal cells in knee osteoarthritis (OA). Primary endpoint: Safety as Measured by Adverse Events at 1 year. Started Mar 2014; status: completed.
02
Drugs
adipose derived mesenchymal stromal cells
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02357485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02357485.